Join
Live feed
·
INSIDERFilingvia Quantisnow
Enanta Pharmaceuticals Inc. logo

Chief Product Strategy Officer Kieffer Tara Lynn sold $18,401 worth of shares (2,283 units at $8.06), decreasing direct ownership by 7% to 29,305 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ENTA· Enanta Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ENTA (Enanta Pharmaceuticals Inc.) and more on Quantisnow.